CHRONIC COMORBIDITIES IN AUTOIMMUNE DISEASES
DOI:
https://doi.org/10.55640/Keywords:
autoimmune diseases, chronic comorbidities, immune dysregulation, inflammationAbstract
Autoimmune diseases are characterized by immune system dysregulation leading to chronic inflammation and tissue damage. Patients with autoimmune disorders frequently develop multiple chronic comorbid conditions, which significantly worsen prognosis, reduce quality of life, and increase healthcare costs. This article aims to analyze the prevalence, mechanisms, and clinical implications of chronic comorbidities in autoimmune diseases. Understanding these associations is essential for improving patient outcomes through early diagnosis and integrated management strategies.
Downloads
References
1.Somers EC, Thomas SL, Smeeth L, Hall AJ. Autoimmune diseases and cardiovascular risk. Ann Rheum Dis. 2015;74(4):666–673.
2.Marrie RA, Walld R, Bolton JM, et al. Increased incidence of psychiatric disorders in autoimmune disease. Neurology. 2017;89(6):586–594.
3.Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2008;59(12):1690–1697.
4.Bruce IN. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2011;25(4):469–484.
5.Dregan A, Charlton J, Chowienczyk P, Gulliford MC. Chronic inflammatory disorders and multimorbidity. BMJ Open. 2014;4:e005867.
6.Mok CC. Comorbidities in systemic lupus erythematosus. Autoimmun Rev. 2017;16(5):451–457.
7.Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in autoimmune diseases. Ann Rheum Dis. 2014;73(1):62–68.
8.van den Hoek J, Boshuizen HC, Roorda LD, et al. Mortality in patients with autoimmune diseases. Arthritis Care Res. 2017;69(8):1204–1212.
9.Hanly JG, Fisk JD, McCurdy G, et al. Depression and anxiety in autoimmune disease. Arthritis Rheumatol. 2014;66(2):406–416.
10.Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India